Mast cell activation triggers Ca 2+ signals and the release of enzyme containing granules, events that play a major role in allergic/hypersensitivity reactions. However, the precise molecular mechanisms that regulate antigen triggered degranulation and Ca 2+ fluxes, in human mast cells, are still poorly understood. Here we show, for the first time, that a receptor can trigger Ca 2+ via two separate molecular mechanisms. Using an antisense approach, we show that IgE-antigen stimulation, of human bone marrow-derived mast cells, triggers a sphingosine kinase 1 (SPHK1)-mediated fast and transient Ca 2+ release from intracellular stores. However, PLCγ1 triggers a second (slower) wave of calcium release from intracellular stores, and it this PLCγ1 generated signal that is responsible for Ca 2+ entry. Surprisingly, FcεRI triggered mast cell degranulation depends on the first, sphingosine kinase-mediated, Ca 2+ signal. These two pathways act independently, since antisense knock down of either enzyme does not interfere with the activity of the other. Of interest, similarly to PLCγ1, SPHK1 rapidly translocates to the membrane, after FcεRI crosslinking. Here we also show that SPHK1 activity depends on phospholipase D1 (PLD1), and that, FcεRI-triggered mast cells degranulation depends primarily on the activation of both PLD1 and SPHK1.
Introduction
Aggregation of the high affinity receptor for IgE (FcεRI) on Mast cells triggers the Ca 2+ dependent release and production of a wide range of mediators responsible for the major symptoms of immediate hypersensitivity reactions (1, 2, 3) . Although some of the signaling cascades triggered by FcεRI have been characterized, the regulatory mechanisms governing mast cell degranulation and calcium release from internal stores are only partially understood. FcεRI is a heterotrimeric receptor complex (αβγ 2 ) that contains immunoreceptor tyrosine-based activation motifs (ITAMs) in both the β and the γ subunit cytoplasmic domains (4) . The protein-tyrosine kinase Lyn is associated with the β subunit in resting cells (5) , and its activation is promoted by FcεRI cross-linking (6) . Activated Lyn phosphorylates ITAMs of the β and γ subunits, resulting in the recruitment of other Src-like as well as Syk protein tyrosine kinases (PTK), through Src homology-2 (SH2) domain-mediated interactions with phosphotyrosine residues (7, 8) . Activation of these newly recruited PTKs, in turn, facilitates the translocation and phosphorylation of multiple signaling molecules, including phospholipase Cγ (PLCγ) isoforms and phosphoinositide 3-kinases (PI3K) (9) . Activated PLCγ hydrolyses phosphatidylinositol 4,5-bisphosphate (PI-4,5-P 2 ) to D-myo-inositol 1,4,5-trisphosphate (Ins-1,4,5-P 3 ) and diacylglycerol (DAG), which induce the release of Ca 2+ from intracellular stores and the activation of protein kinase C isoforms (PKCs), respectively. The amplitude and duration of the Ca 2+ response potentially modulates the activation of different transcription factors (10) , regulating different gene expression. Ca 2+ signals are also indispensable for the release of histamine containing granules (1) , the synthesis of arachidonic acid-derived mediators and the release and generation of various cytokines (2) , which together are responsible for the major symptoms of immediate hypersensitivity reactions. Thus, an understanding of mast cell activation, and Ca 2+ signaling, therefore, has obvious therapeutic implications. It has previously been shown that FcεRI, on the rat mast cell line RBL-2H, triggers Ca 2+ signals via a novel pathway potentially involving sphingosine kinase activity (11) and not phospholipase Cγ, even though IP 3 production was observed (11) . We have recently shown that a similar receptor, FcγRI in monocytes, triggers intracellular Ca 2+ via the sequential activation of phospholipase D and sphingosine kinase (12) ; however, no IP 3 generation was observed in this case (12) .
Phospholipase D hydrolysis phosphatidylcholine (PtdCho) to yield phosphatidic acid (PA) and choline (13) , PA has been shown to play many intracellular signaling functions (13, 14) , including the activation of sphingosine kinase (SPHK) (14) (15) (16) . SPHK phosphorylates sphingosine to generate sphingosine-1-phosphate (SPP) (15, 16, 17) . SPP has been demonstrated to act as an alternative second messenger to Inositol-1,4,5-trisphosphate in the release of Ca 2+ from intracellular stores (11, 12) . In this study we show, for the first time, a dual molecular mechanism responsible for triggering different calcium signals. Firstly, a rapid rise in internal calcium, triggered by the sequential activation of phospholipase D1 (PLD1) and sphingosine kinase 1 (SPHK1). Secondly a prolong calcium response is triggered by phospholipase Cγ1. Furthermore, mast cell degranulation is triggered by the combined action of PLD1 and SPHK1. However, the PLCγ1 activation is necessary to trigger calcium entry into the cells.
Understanding the intracellular signaling pathways coupling FcεRI activation, by IgE-antigen, to physiological responses triggered by mast cell activation has profound therapeutic implications for allergic/inflammatory diseases.
Materials and Methods
Unless stated differently all chemicals and reagents were obtained from Sigma.
BMMC Generation, and cell culture
Bone marrow was collected from human donors following the protocol approved by the FDA Committee for Research Involving Human Subjects. Normal donor eligibility criteria include healthy males and non-pregnant females between the ages of 18 and 45 years old. The donors must have a negative medical history for all major diseases. Bone marrow was withdrawn by board-certified physicians from two separate sites of the posterior pelvic bone into syringes containing preservative-free heparin sodium injection (20-50 units heparin per ml bone marrow). BMMCs were generated using the, previously described 18, following protocol: fresh human bone marrow cells were cultured in complete RPMI 1640 supplemented with 10ng/ml IL-3 (Calbiochem) and 100ng/ml Stem Cell Factor (Calbiochem) for two weeks. Cells were characterized as BMMCs by flow cytometry as CD45+, CD117+, CD9+, positive with FITClabeled human IgE, CD4-, CD8-, CD45-, CD11b-, CD11c-, and MHC class II-. Purity was estimated at >95%. All antibodies were FITC or biotin labeled (Serotec).
Antisense oligonucleotides were purchased from Oswell DNA Services; 20-mers were synthesised, capped at either end by the phosphorothiorate linkages (first two and last two linkages), and corresponded to the reverse complement of the first 20 coding nucleotides for PLD1, SPHK1, PLCγ1, and a scrambled oligo for control. The sequences of the oligonucleotides were: 5'CCGTGGCTCGTTTTTCAGTG 3' for PLD1, 5'CCCGCAGGATCCATAACCTC 3' for SPHK1. 5'GGGGACGCGGCGCCCGCCAT 3' for PLCγ1.
5'CTGGTGGAAGAAGAGGACGT 3' scrambled for control
Cells were incubated/transfected with 1µM oligonucleotides mixed with transfection reagent (FuGene, Roche) for a total of 48 hrs (36 hrs prior to, and then for the duration of sensitisation).
Reverse Transcription PCR
mRNA from BMMC was isolated using the Quiagen midi kit for mRNA extraction. Specific forward (TGAACCCGCGCGGCAAGGGC) and reverse (GGTCAGCCGGCGCCATCCACG) primers were designed for the human SPHK1 to yield a 570 bp fragment.
Peptide-derived polyclonal antibody specific for the human SPHK1
A peptide sequence, specific for the human SPHK1, was selected for its apparent hydrophobisity properties, and synthesised.
Peptide: FIADVDLESEKYRRLGEMRFTLGT. Two rabbits were immunised giving rise to two peptide-derived antisera. The polyclonal antibodies were purified using protein-A agarose affinity columns. The polyclonal antibodies only recognised one band, in western blots, for the correct molecular weight of endogenous, or recombinant human SPHK1. The antibody was also successfully used, as primary antibody, for immune-staining for confocal microscopy analysis.
FcεRI aggregation
BMMC cells were sensitized with 1µg/ml human DNP-specific IgE overnight. Then cells were collected, washed, resuspended in RPMI-1% FBS, activated by the antigen DNP-BSA (1µg/ml), and activation stopped at the times indicated in the figures.
Cell lyses and subcellular fractionation
For translocation experiments, cell lyses and subcellular fractions were prepared following the method previously described (19) . Briefly, cells were harvested and resuspended in cold nuclear preparation lyses buffer (10 mM Tris-HCL, pH 7.4, 2 mM magnesium chloride, 140 mM sodium chloride, 1% Triton X100, 0.25% sodium deoxycholate, 1 mM EGTA, 1 mM PMSF, 10 mM sodium orthovanadate, 10 µg/ml chymostatin, 10 µg/ml leupeptin, 10 µg/ml antipain and 10 µg/ml pepstatin). After lyses by freeze thaw (x 3 in liquid nitrogen), from the total cell lysates, the nuclei and cell debris (containing the cytoskeleton) were removed by centrifugation at 15,000 g for 5 min. The supernatant was centrifuged at 100,000 g and 4°C for 60 min. The pellet containing the nuclear-free membrane fraction was resuspended in 200 µl of nuclear preparation buffer (without detergents) and stored at -20 °C. The amount of protein recovered in each fraction was quantified using the Bradford reagent system (Bio-Rad, UK).
Gel Electrophoresis and Western Blots
Unless stated otherways, 40 µg of lysate for each sample was resolved on 10% polyacrylamide gels (SDS-PAGE) under denaturing conditions and then transferred to 0.45µm nitrocellulose membranes. For translocation experiments, 40 µg of lysate for each sample was fractionated as mentioned above, the supernatant and the membrane fractions for each sample were separately resolved on 10% polyacrylamide gels (SDS-PAGE) under denaturing conditions and then transferred to 0.45µm nitrocellulose membranes. After blocking overnight at 4°C with 5% nonfat milk in TBS, 0.1% Tween 20 and washing, the membranes were incubated with the relevant antibodies for 4 hr at room temperature. The membranes were washed extensively in TBS/0.1% Tween 20 (washing buffer). The blots were probed using specific, monoclonal (anti-PLCγ1, Santa Cruz) ; polyclonal (anti-PLD1, QCB) ; (anti-SPHK1 made in house as described) ; primary antibodies. Blots were stripped and reprobed with policlonal antibodies: an anti-PDGFRα antibody (against the alpha subunit of the PDGF receptor, Santa Cruz), for membrane loading control; or with an anti-HSP 90 (H-114, against the heat shock protein 90, Santa Cruz) for cytosol loading control. The anti-PDGFα antibody was also used as a loading control for blots containing whole cell lysates. Bands were visualised using the appropriate HRP-conjugated secondary antibody, and the ECL Western Blotting Detection System (Amersham, UK).
Phospholipase D (PC-PLD) activity
PLD activity was measured as previously described (12) The accumulated phosphatidyl butanol was assayed as described previously (12) .
Inositol-1,4,5-trisphosphate
Inositol-1,4,5-trisphosphate (IP 3 ) was measured as previously described (20) , using the BIOTRAK TRK 1000 kit (Amersham-Pharmacia). Briefly, this is a competition binding assay in which cellular generated (unlabelled) IP 3 competes with a fixed, known amount of [ 3 H]IP 3 for binding to the IP 3 receptor present in homogenates from bovine adrenal glands, which has a high affinity and specificity for IP 3 . FcεRI aggregation was carried out described above, and activation stopped at the times indicated in the figures.
Sphingosine kinase activity
Activation of sphingosine kinase was measured as described previously (12, 21) . Briefly, cells were resuspended in ice-cold 0.1 M phosphate buffer (pH 7.4) containing 20% glycerol, 1 mM mercaptoethanol, 1 mM EDTA, phosphatase inhibitors (20 mM ZnCL 2 , 1 mM sodium orthovanadate, and 15 mM sodium fluoride), protease inhibitors (10 µg/ml leupeptin, 10 µg/ml aprotinin, and 1 mM PMSF), and 0.5 mM 4-deoxypyridoxine, disrupted by freeze thawing and centrifuged at 105,000 g for 90 min at 4ºC. Supernatants (cytosolic) and particulate (membrane) fractions were assayed for sphingosine kinase activity by incubating with sphingosine (Sigma) and [γ 32 P]ATP (2 µCi, 5 mM) for 30 min at 37ºC and products were separated by TLC on silica gel G60 (Whatman, U.K.) using chloroform/methanol/acetic acid/water (90:90:15:6) and visualized by autoradiography. The radioactive spots corresponding to sphingosine phosphate were scraped and counted in a scintillation counter.
Cytosolic Ca 2+
Cytosolic calcium was measured as described previously (12, 21) , except that for some experiments the buffer was Ca 2+ supplemented (final concentration 1.5 mM Ca 2+ ). Briefly, sensitized cells were loaded with 1 µg/ml Fura2-AM (Molecular Probes, Leiden, The Netherlands) in PBS, 1.5 mM Ca 2+ and 1 % BSA. After removal of excess reagents by dilution and centrifugation, the cells were resuspended in 1.5 mM Ca 2+ supplemented PBS and warmed to 37°C in the cuvette. FcεRI was aggregated as described above. Fluorescence was measured at 340 and 380 nm and the background-corrected 340:380 ratio was calibrated as previously described (12) .
Confocal microscopy
After receptor aggregation, suspended cells were fixed in 4% paraformaldehyde and deposited on microscope slides in a cytospin centrifuge, then permeabilised for 5 min in 0.1% Triton X100 in PBS. Fluorescent labeling was performed as previously described (22), using anti-PLCγ1 monoclonal antibody (Santa Cruz), or anti-SPHK1 polyclonal (made in house as described), as primary antibodies. Stainings were analyzed in horizontal confocal microscopy sections (50-100 sections of 0.2 µm), recorded by a Leica TCS NT, and images deconvoluted. Signals were projected into one image as an extended focus view.
β-Hexosaminidase release
Degranulation was measured using a previously described (23) 
Results
In this study we explored the molecular mechanisms regulating receptor coupling to various lipid modifying-enzymes and relate these to the triggering of Ca 2+ signals, and degranulation.
Since SPHK had been shown to play a potential role in triggering Ca 2+ release from intracellular stores, we decided to investigate whether SPHK is indeed involved in the FcεRI triggering of Ca 2+ signals in the human mast cells. Two human sphingosine kinases have recently been cloned and characterized, namely sphingosine kinase 1 (SPHK1) (15) , and sphingosine kinase 2 (SPHK2) (17) . First, the presence of specific SPHK isozymes present in the cells was examined.
In bone marrow-derived mast cells only SPHK1 was found by RTPCR ( Figure 1A) , and by western blot ( Figure 1B) . Western blot analysis showed that SPHK1, in resting cells, is found primarily in the cytosolic fraction of the cells (Figure 1B upper) . However, aggregation of FcεRI resulted in the rapid translocation of SPHK1, from the cytosol to the nuclear-free membrane fraction ( Figure 1B lower) . In agreement with this, confocal microscopy also shows that in resting cells SPHK1 is primarily cytosolic, but after receptor engagement it rapidly translocates to the cell periphery ( Figure 1C ).
Sphingosine kinase activity, and its product sphingosine-1-phosphate (SPP), has been shown to be involved in many cellular processes, including Ca 2+ signals (11, 12) , suppression of ceramide-mediated apoptosis (24) , and cell survival and proliferation (24) . However, the regulation of SPHK activity is still poorly understood. We have previously shown that a similar receptor, FcγRI in monocytic cells, triggers sphingosine kinase activity dependent on phospholipase D (PLD) activation (11, 21) . There is also in-vitro evidence for the regulation of SPHK activity by acidic phospholipids (such as phosphatidic acid, the direct product of PLD activity) (16). Here we show that in the human bone marrow-derived mast cells FcεRI couples to PLD1 to activate SPHK1. Antisense to PLD1 blocks FcεRI triggered PLD activity ( Figure 2A upper), and considerably reduced endogenous PLD1 expression levels to only 18% + 5% of the PLD1 expressed in the control cells taken as 100% (Figure 2A lower) . In resting cells, very little SPHK activity is observed, however, following FcεRI crosslinking SPHK activity very rapidly increases ( Figure 2B ). In agreement with the translocation experiments ( Figures 1A and 1C) , very little SPHK activity is observed in the membrane fraction of resting cells, however, following FcεRI crosslinking, SPHK activity very rapidly increases in the membrane fraction to higher levels than that observed in the cytosolic fraction ( Figure 2B , right and left, respectively).
Moreover, antisense to PLD1 blocked the FcεRI triggered SPHK1 activity ( Figure 2B upper) , but had no effect on SPHK1 expression (Figure 2B lower) . Furthermore, an antisense to SPHK1 blocked FcεRI triggered sphingosine kinase activity ( Figure 2B upper) , and had no effect on PLD activity ( figure 2A upper) , or on PLD1 expression levels (Figure 2A lower) , but considerably reduced endogenous SPHK1 expression levels to only 15% + 5% of the SPHK1 expressed in the control cells taken as 100% (Figure 2B lower) . The scrambled oligo used as control had no effect on the level of expression of either protein. These data suggest that SPHK1 is downstream of PLD1 activity in the FcεRI triggered signal transduction pathways.
In the rat mast cell line RBL-2H, Choi and co-workers (11) showed that FεRI triggered Ca 2+ release from intracellular stores was dependent on sphingosine kinase activity, by addition of the non-selective sphingosine kinase inhibitor dihydrosphingosine (DHS); which reduced the increase in Ca 2+ in response to antigen, while the antigen induced production of IP 3 was unimpaired. However, IP 3 is widely known to trigger the release of Ca 2+ from intracellular stores by activating specific receptors on the membranes of these stores (25, 26) , and PLCγ has been shown to be phosphorylated, and to translocate following FcεRI triggering in rat mast cells (27, 28) . To determine whether in the human mast cells, FcεRI triggers IP 3 -generation and IP 3 -mediated Ca 2+ release, IP 3 generation was monitored over time. We found that, in the human mast cells, PLC is activated by FcεRI, as shown by the generation of IP 3 ( Figure 3A) . Moreover, PLCγ1 is the PLC isoform that translocates to the membrane, following FcεRI engagement ( Figure 3B upper) . Furthermore, antisense to PLCγ1 inhibited IP 3 generation triggered by FcεRI ( Figure 3A) , and dowregulated the endogenous PLCγ1 expression levels ( Figure 3B lower). Antisense to SPHK1 had no effect on IP 3 production ( Figure 3A) , or on PLCγ1 expression levels ( Figure 3B lower) .
For all experiments the antisense transfection efficiency was very even, an average 85% of the cells treated with any of the antisense used showed complete downregulation in the expression levels of the targeted protein (FACS analysis, data not shown).
In order to clarify the roles of SPHK1 and/or PLCγ1 in the Ca 2+ signals generated following FcεRI engagement, we next used the antisense oligonucleotides against the human SPHK1 and PLCγ1, to demonstrate which pathway was responsible for Ca 2+ triggering in the human mast cells.
It was found that antisense downregulation of SPHK1 substantially inhibited the initial rise in Ca 2+ release from intracellular stores ( Figure 4A) ; however, Ca 2+ entry was unaffected ( Figure   4A ). In cells pretreated with antisense to PLCγ1 the first peak in Ca 2+ was unaffected ( Figure   4B ), however, calcium entry was reduced ( Figure 4B ). Experiments without extracellular Ca 2+
showed that the first, initial, rise in intracellular Ca 2+ is due to SPHK1 ( Figure 4C ), whereas, a second (smaller) increase in Ca 2+ release from internal stores was dues to PLCγ1 ( Figure 4C ). A combination of both, antisense to SPHK1 and PLCγ1, completely blocked the calcium response triggered by FcεRI ( Figure 4D ). The use of specific inhibitors for SPHK, N,N-dimethylsphingosine (DMS); or for PLC, ET-18-OCH 3 , generated similar results as those observed with the antisense oligonucleotides (data not shown).
These results show that FcεRI triggers Ca 2+ signals by two different pathways. Firstly, a novel pathway that uses SPHK1, and is responsible for the initial strong Ca 2+ released from internal stores. Secondly, a more classical pathway that triggers IP 3 generation via PLCγ, which triggers a second although smaller peak in Ca 2+ release from intracellular stores, but which is responsible for triggering Ca 2+ entry.
In contrast to previous studies in rat mast cells (11) , the non-selective tyrosine kinase inhibitor, genistein, completely blocked SPHK activity and IP 3 generation ( Figures 5A and 5B) , as well as FcεRI induced PLD activity, but had no effect on PMA induced PLD activity, suggesting that the tyrosine kinase inhibitor does not directly inhibits PLD activity ( Figure 5C ). The FcεRI triggered membrane translocation of SPHK1 and PLCγ1 was also inhibited by the tyrosine kinase inhibitor ( Figures 5D and 5E, respectively) . Moreover, the Ca 2+ signals triggered by FcεRI, were also completely blocked in cells pretreated with genistein ( Figure 5D ). These data show that SPHK1 and PLCγ1 activities, as well as all the Ca 2+ signals triggered by FcεRI, are completely tyrosine kinase dependent.
Mast cells degranulation has been shown to be Ca 2+ dependent (2, 3) , and linked to Phospholipase D activity (23, 29, 30) . Antisense downregulation of different PLD isoforms is proving a very useful tool in dissecting the functions of each particular isoenzyme (31) .
Antisense downregulation of PLD1 substantially inhibits FcεRI triggered mast cell degranulation ( Figure 6A ), but has no effect on IP 3 generation ( Figure 6B) . Similarly, antisense to SPHK1 also inhibited enzyme release ( Figure 6A) , and a combination of antisense to PLD1 and SPHK1 almost completely inhibited FcεRI triggered degranulation ( Figure 6A ), but had no effect on IP 3 production. Antisense to PLCγ1 had no effect on enzyme release ( Figure 6A ), but significantly reduced IP 3 generation ( Figure 6B ).
These results show that both PLD1 and SPHK1 are necessary for FcεRI to trigger mast cell degranulation.
Discussion
Taken together, the data presented here demonstrates that the activation of FcεRI by surface IgE-antigen complexes, on human bone marrow-derived mast cells, stimulates two different pathways to trigger Ca 2+ release from internal stores. A novel pathway, that couples phospholipase D1 (PLD1) to sphingosine kinase1 activation (SPHK1), is responsible for the initial peak in the FcεRI generated Ca 2+ signals as well as the mast cell degranulation; and a more classical pathway which triggers PLCγ1 activity and IP 3 dependent second wave of Ca 2+ release from internal stores, as well as Ca 2+ entry into the cells.
The activation of sphingosine kinase and the generation of sphingosine-1-phosphate have been previously proposed to play a role in mobilizing calcium from intracellular stores (11, 12, (32) (33) (34) . However, this proposal has proven highly controversial due to the presence of extracellular G protein-coupled receptors for sphingosine-1-phosphate (35, 36) , which are able to mobilize calcium through conventional IP 3 receptor-dependent pathways. However, the resent cloning of the SCaMPER receptor (37) provides additional evidence that sphingoid derivatives are able to engage intracellular receptors and effect calcium release from intracellular stores independently of IP 3 generation. The data presented here provide evidence for specific immune receptor triggering of this pathway in mast cells. Thus, aggregation of FcεRI resulted in the rapid membrane translocation and activation of SPHK1. The results presented in this report demonstrate that the initial peak in Ca 2+ release from intracellular stores, triggered by FcεRI, is dependent on sphingosine kinase activity. In this respect, FcεRI aggregation in human mast cells is behaving like in the rat mast cell line RBL-2H (11), and like the high affinity IgG receptor, FcγRI, in human myeloid cells (12) . Of interests, both these receptors use the same signaltransducing molecule (γ-chain) to recruit soluble tyrosine kinases (38, 39) . However, unlike the study in the RBL-2H cells (11) , and that of FcγRI in human myeloid cells (12), a second peak in Ca 2+ release from internal stores, as well as Ca 2+ influx to the cells, triggered by FcεRI in mast cells, was dependent on PLCγ1 activation. The mechanism of coupling of tyrosine kinases to sphingosine kinase activation following FcεRI aggregation in the RBL-2H cells was unclear (11) . Here, we demonstrate that PLD1 is activated following FcεRI aggregation in human mast cells and that SPHK1 activation is dependent on PLD1 activation. The immediate product of PtdCho-PLD is phosphatidic acid, and this is subsequently converted to DAG through the action of phosphatidic acid phosphohydrolases (14) . Previous studies have shown that sphingosine kinase is activated by phosphatidic acid (16, 40) and not by DAG (16, 40) (6), and phagocytosis (43) . In the study reported here, inhibiting this pathway at either PLD1 or SPHK1 level reduced the ability of this receptor to mobilize Ca 2+ from intracellular stores. In addition, the inhibition of PLD and/or sphingosine kinase significantly reduced enzyme release/degranulation. Of interest, ADP-ribosylation factor (ARF) plays a major role in regulating vesicular trafficking (44) (45) (46) , and this small weight G protein has also been demonstrated to regulate phospholipase D activity (31, (45) (46) (47) .
This potential diversity of phospholipid signaling pathways offers the opportunity within the cell to very tightly regulate different physiological events of the cell effector mechanisms. The finding that FcεRI is coupled to the release of calcium from intracellular stores and enzyme release/degranulation via a novel pathway has profound implication for the development of strategies for therapeutic intervention against different allergic and inflammatory responses. A. RTPCR analysis of mRNA expression levels before sensitization (1) 
